US Patent Issued to GI INNOVATION on May 6 for "Fusion protein comprising IL-2 protein and CD80 protein, and use thereof" (South Korean Inventor)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,555, issued on May 6, was assigned to GI INNOVATION INC. (Seoul, South Korea).

"Fusion protein comprising IL-2 protein and CD80 protein, and use thereof" was invented by Myung Ho Jang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a fusion protein comprising IL-2 protein and CD80 protein. A fusion protein containing CD80 fragment, immunoglobulin Fc, and an IL-2 variant can activate immune cells, such as natural killer cells, and at the same time, can control immune cell regulatory activity of regulatory T cells. Therefore, a pharmaceutical composition containing the fusion protein as an active ingredient is very indus...